Cargando…

The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study

BACKGROUND: Few antibiotics have entered the market in recent years despite the need for new treatment options. Some of the challenges of bringing new antibiotics to market are linked to the marketing authorization and health technology assessment (HTA) processes. Research shows great variation in g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kållberg, Cecilia, Mathiesen, Liv, Gopinathan, Unni, Salvesen Blix, Hege
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045501/ https://www.ncbi.nlm.nih.gov/pubmed/36973761 http://dx.doi.org/10.1186/s40545-023-00556-x

Ejemplares similares

An antibiotic’s journey from marketing authorization to use, Norway
por: Årdal, Christine, et al.
Publicado: (2017)

The effect of generic market entry on antibiotic prescriptions in the United States
por: Kållberg, Cecilia, et al.
Publicado: (2021)

Introduction and geographic availability of new antibiotics approved between 1999 and 2014
por: Kållberg, Cecilia, et al.
Publicado: (2018)

Non-prescription purchase of antibiotics during travel abroad among a general adult population in Norway: Findings from the seventh Tromsø Study
por: Gravningen, Kirsten, et al.
Publicado: (2020)

Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Gopinathan, Unni, et al.
Publicado: (2020)

Targets for the reduction of antibiotic use in humans in the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) partner countries
por: D’Atri, Fabio, et al.
Publicado: (2019)

Antibiotic use in children before, during and after hospitalisation
por: Thaulow, Christian Magnus, et al.
Publicado: (2022)

Comedication and Treatment Length in Users of Acetylcholinesterase Inhibitors
por: Sverdrup Efjestad, Anne, et al.
Publicado: (2017)

Academic detailing as a method to improve general practitioners’ drug prescribing in type 2 diabetes: evaluation of changes in prescribing
por: Langaas, Harald Christian, et al.
Publicado: (2023)

Can We Optimize Antibiotic Use in Norwegian Neonates? A Prospective Comparison Between a University Hospital and a District Hospital
por: Thaulow, Christian Magnus, et al.
Publicado: (2019)

Corrigendum: Can We Optimize Antibiotic Use in Norwegian Neonates? A Prospective Comparison Between a University Hospital and a District Hospital
por: Thaulow, Christian Magnus, et al.
Publicado: (2022)

Identifying targets for antibiotic stewardship interventions through analysis of the antibiotic prescribing process in hospitals - a multicentre observational cohort study
por: Wathne, Jannicke Slettli, et al.
Publicado: (2020)

Using a period incidence survey to compare antibiotic use in children between a university hospital and a district hospital in a country with low antimicrobial resistance: a prospective observational study
por: Thaulow, Christian Magnus, et al.
Publicado: (2019)

Drug Use before and after Initiating Treatment with Acetylcholinesterase Inhibitors
por: Efjestad, Anne Sverdrup, et al.
Publicado: (2019)

Sex differences in psychotropic and analgesic drug use before and after initiating treatment with acetylcholinesterase inhibitors
por: Efjestad, Anne Sverdrup, et al.
Publicado: (2021)

Use of Drugs With Risk of Heart Rate-Related Problems is Common in Norwegian Dementia Patients Treated With Acetylcholinesterase Inhibitors: A Prevalence Study Based on the Norwegian Prescription Database
por: Efjestad, Anne Sverdrup, et al.
Publicado: (2022)

The effect of antibiotic stewardship interventions with stakeholder involvement in hospital settings: a multicentre, cluster randomized controlled intervention study
por: Wathne, Jannicke Slettli, et al.
Publicado: (2018)

A multidisciplinary approach to improve drug therapy in nursing homes
por: Davidsson, Malin, et al.
Publicado: (2011)

Drug use differs by care level. A cross-sectional comparison between older people living at home or in a nursing home in Oslo, Norway
por: Fog, Amura Francesca, et al.
Publicado: (2019)

The association between adherence to national antibiotic guidelines and mortality, readmission and length of stay in hospital inpatients: results from a Norwegian multicentre, observational cohort study
por: Wathne, Jannicke Slettli, et al.
Publicado: (2019)

Epidemiological studies for regulatory agencies.
por: Hunt, V R
Publicado: (1981)

Bacteriology in uncomplicated urinary tract infections in Norwegian general practice from 2001–2015
por: Bollestad, Marianne, et al.
Publicado: (2017)

Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies
por: Lehoux, Pascale, et al.
Publicado: (2017)

Decisions by regulatory agencies: are they evidence-based?
por: Furberg, Curt D
Publicado: (2007)

Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model
por: Brogan, David M, et al.
Publicado: (2013)

Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus
por: Morel, Chantal M., et al.
Publicado: (2020)

Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study
por: Tauqeer, Fatima, et al.
Publicado: (2019)

The Role of Intentional Strength in Shaping the Sense of Agency
por: Antusch, Samantha, et al.
Publicado: (2019)

Incidence Trends of Atopic Dermatitis in Infancy and Early Childhood in a Nationwide Prescription Registry Study in Norway
por: Mohn, Cathrine H., et al.
Publicado: (2018)

Assessing improvement capability in healthcare organisations: a qualitative study of healthcare regulatory agencies in the UK
por: Furnival, Joy, et al.
Publicado: (2018)

Scientific Advisory Committees at the World Health Organization: A Qualitative Study of How Their Design Affects Quality, Relevance, and Legitimacy
por: Gopinathan, Unni, et al.
Publicado: (2018)

A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency
por: Keyter, Andrea, et al.
Publicado: (2020)

International regulatory agencies: Indian clinical trials
por: Bhatt, Arun
Publicado: (2011)

Regulatory Agencies and PET/CT Imaging in the Clinic
por: Herscovitch, Peter
Publicado: (2022)

Energy, sustainability and the environment: technology, incentives, behavior
por: Sioshansi, Fereidoon P
Publicado: (2011)

The sense of agency shapes body schema and peripersonal space
por: D’Angelo, Mariano, et al.
Publicado: (2018)

How are drug regimen changes during hospitalisation handled after discharge: a cohort study
por: Viktil, Kirsten K, et al.
Publicado: (2012)

Book review: Human Rights in Global Health: Rights-Based Governance for a Globalizing World
por: Gopinathan, Unni
Publicado: (2019)

Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: Gopinathan, Unni
Publicado: (2023)

Use of Statins in Kidney Transplant Recipients in Norway
por: Rønning, Marit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e541chfjvkfuitq0iii5gg75rf